br Conclusions br Target localization for cervix cancer RT is
Target localization for cervix cancer RT is similar for CBCT and US. Aweak association between PD98059 size and contour confidence on US images was observed, suggesting that larger bladder sizes may improve the quality of US images of the uterus. The combination of CBCT and US further im-proves the precision of target localization. Initial findings indicate that in cases in which the uterus is clearly visualized on US, US can be used as an alternative to CBCT for uterine localization, with the benefit of a reduction in radiation exposure and improved cost-effectiveness. Combined CBCT-US imaging could be used to implement adaptive planning strategies for cervix cancer RT.
1. Lim K, Small W Jr., Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys 2011;79:348-355.
2. Bondar ML, Hoogeman MS, Mens JW, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys 2012;83:1617-1623.
3. Chan P, Dinniwell R, Haider MA, et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer under-going radiotherapy: A cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys 2008;70:1507-1515.
4. Collen C, Engels B, Duchateau M, et al. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2010;77:1590-1595.
5. Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 2014;26:185-196.
6. Brixey CJ, Roeske JC, Lujan AE, et al. Impact of intensity modulated radiotherapy on haemotolgic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1388-1396.
8. Mell LK, Kochanski JD, Roeske JC, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:1356-1365.
9. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol 2003;56: 1354-1360.
10. Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48:1613-1621.
12. Heijkoop ST, Langerak TR, Quint S, et al. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Int J Radiat Oncol Biol Phys 2014;90:673-679.
13. Heijkoop ST, Langerak TR, Quint S, et al. Quantification of intra-fraction changes during radiotherapy of cervical cancer assessed with pre- and post-fraction cone beam CT scans. Radiother Oncol 2015;117:536-541.
14. Langerak T, Heijkoop S, Quint S, et al. Towards automatic plan se-lection for radiotherapy of cervical cancer by fast automatic seg-mentation of cone beam CT scans. Med Image Comput Comput Assist Interv 2014;17:528-535.
15. Lu¨tgendorf-Caucig C, Fotina I, Stock M, et al. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: Multi-observer and image multi-modality study. Radiother Oncol 2011;98:154-161.
16. Maemoto H, Toita T, Ariga T, et al. Predictive factors of uterine movement during definitive radiotherapy for cervical cancer. J Radiat Res 2017;58:397-404.
17. Tyagi N, Lewis JH, Yashar CM, et al. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer. Int J Radiat Oncol Biol Phys 2011;80: 273-280.